IN-1233-eluting covered metallic stent to prevent hyperplasia: Experimental study in a rabbit esophageal model

Radiology

Volumn 267, Issue 2, 2013, Pages 396-404

  Kim, Eun Young ^a   Song, Ho Young ^a   Kim, Jin Hyoung ^a   Fan, Yong ^b   Park, Sangsoo ^c   Kim, Dae Kee ^d   Lee, Edward W ^e   Na, Han Kyu ^a  

^a University of Ulsan   (South Korea)

^b Haihe Hospital   (China)

^c Eulji University   (South Korea)

^d Ewha Womans University   (South Korea)

^e UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[4 (6 METHYLPYRIDIN 2 YL) 5 (QUINOLIN 6 YL) 1H IMIDAZOL 2 YL]METHYL]BENZAMIDE; IN 1233; POLYURETHAN; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG ELUTING STENT; DRUG RELEASE; EPITHELIUM; ESOPHAGOGRAPHY; ESOPHAGUS STENOSIS; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; FIBROSIS; GRANULATION TISSUE; HYPERPLASIA; IN VITRO STUDY; MALE; METAL STENT; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT; SELF EXPANDING STENT;

ANIMALS; BENZAMIDES; DRUG-ELUTING STENTS; ESOPHAGUS; HYPERPLASIA; MALE; METALS; POLYURETHANES; QUINOLINES; RABBITS; STATISTICS, NONPARAMETRIC;

EID: 84876922037     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120361     Document Type: Article

References (36)

1. Orons PD, Amesur NB, Dauber JH, Zajko AB, Keenan RJ, Iacono AT. Balloon dilation and endobronchial stent placement for bronchial strictures after lung transplantation. J Vasc Interv Radiol 2000;11(1):89-99.
2. Song HY, Park H, Suh TS, et al. Recurrent traumatic urethral strictures near the external sphincter: treatment with a covered, retrievable, expandable nitinol stent -initial results. Radiology 2003;226(2):433-440.
3. Holm AN, de la Mora Levy JG, Gostout CJ, Topazian MD, Baron TH. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc 2008;67(1):20-25.
4. Kennedy AS, Sonett JR, Orens JB, King K. High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations. J Heart Lung Transplant 2000;19(2):155-159.
5. Kim DK, Bang YJ, Kim HT, et al. 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors. US Patent Appl US2008.
6. Kim JH, Song HY, Park JH, Yoon HJ, Park HG, Kim DK. IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model. Radiology 2010;255(1):75-82.
7. Yoon HJ, Song HY, Kim JH, et al. Role of IN-1233 in the prevention of neointimal hyperplasia after stent placement in a rat artery model. J Vasc Interv Radiol 2011;22(9):1321-1328.
8. Karagiannidis C, Velehorschi V, Obertrifter B, Macha HN, Linder A, Freitag L. High-level expression of matrix-associated transforming growth factor-beta1 in benign airway stenosis. Chest 2006;129(5):1298-1304.
9. Liu W, Wang DR, Cao YL. TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 2004;4(1):123-136.
10. Shin JH, Lee SK, Song HY, et al. The effects of 188 rhenium-filled balloon dilation following bare stent placement in a rabbit oesophageal model. Br J Radiol 2008;81(965):413-421.
11. Shin JH, Song HY, Seo TS, et al. Influence of a dexamethasone-eluting covered stent on tissue reaction: an experimental study in a canine bronchial model. Eur Radiol 2005;15(6):1241-1249.
12. Kim EY, Shin JH, Jung YY, Shin DH, Song HY. A rat esophageal model to investigate stent-induced tissue hyperplasia. J Vasc Interv Radiol 2010;21(8):1287-1291.
13. Ross WA, Alkassab F, Lynch PM, et al. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 2007;65(1):70-76.
14. Song HY, Do YS, Han YM, et al. Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology 1994;193(3):689-695.
15. Shin JH, Song HY, Kim JH, et al. Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma. J Vasc Interv Radiol 2005;16(1):67-74.
16. Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 2001;12(4):465-474.
17. Song HY, Park SI, Do YS, et al. Expandable metallic stent placement in patients with benign esophageal strictures: results of long-term follow-up. Radiology 1997;203(1):131-136.
18. Cwikiel W, Willén R, Stridbeck H, Lillo-Gil R, von Holstein CS. Self-expanding stent in the treatment of benign esophageal strictures: experimental study in pigs and presentation of clinical cases. Radiology 1993;187(3):667-671.
19. Tan BS, Kennedy C, Morgan R, Owen W, Adam A. Using uncovered metallic endoprostheses to treat recurrent benign esophageal strictures. AJR Am J Roentgenol 1997;169(5):1281-1284.
20. Kim JH, Shin JH, Song HY, Shim TS, Yoon CJ, Ko GY. Benign tracheobronchial strictures: long-term results and factors affecting airway patency after temporary stent placement. AJR Am J Roentgenol 2007;188(4):1033-1038.
21. Guo JH, Teng GJ, Zhu GY, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology 2008;247(2):574-581.
22. McLoughlin MT, Byrne MF. Endoscopic stenting: where are we now and where can we go World J Gastroenterol 2008;14(24):3798-3803.
23. Dirks K, Schulz T, Schellmann B, Stolte M, Lutz H. Fatal Hemorrhage following perforation of the aorta by a barb of the Gianturco-Rösch esophageal stent. Z Gastroenterol 2002;40(2):81-84.
24. Baron TH. A practical guide for choosing an expandable metal stent for GI malignancies: is a stent by any other name still a stent? Gastrointest Endosc 2001;54(2):269-272.
25. Jeon SR, Eun SH, Shim CS, et al. Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study. Endoscopy 2009;41(5):449-456.
26. Rubin P, Soni A, Williams JP. The molecular and cellular biologic basis for the radiation treatment of benign proliferative diseases. Semin Radiat Oncol 1999;9(2):203-214.
27. Diamond DA, Vesely TM. The role of radiation therapy in the management of vascular restenosis. Part I. Biologic basis. J Vasc Interv Radiol 1998;9(2):199-208.
28. Saugel B, Gaa J, Phillip V, Schmid RM, Huber W. Life-threatening erosion bleeding of the carotid artery after esophagectomy: emergency placement of a covered carotid artery stent. J Vasc Interv Radiol 2010;21(1):161-162.
29. Gupta M, Kadakia J, Budoff MJ. Management of restenosis in drug-eluting stents: still a challenge! J Invasive Cardiol 2010;22(5):220-221.
30. Pendyala L, Jabara R, Shinke T, et al. Drug-eluting stents: present and future. Cardiovasc Hematol Agents Med Chem 2008;6(2):105-115.
31. Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 1992;119(5):1017-1021.
32. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992;90(1):1-7.
33. Long L, Crosby A, Yang X, et al. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation 2009;119(4):566-576.
34. Heinrich NA, McKeever PJ, Eisenschenk MC. Adverse events in 50 cats with allergic dermatitis receiving ciclosporin. Vet Dermatol 2011;22(6):511-520.
35. Farb A, John M, Acampado E, Kolodgie FD, Prescott MF, Virmani R. Oral everolimus inhibits in-stent neointimal growth. Circulation 2002;106(18):2379- 2384.
36. Kim JH, Song HY, Shin JH, et al. Membrane degradation of covered stents in the upper gastrointestinal tract: frequency and clinical significance. J Vasc Interv Radiol 2008;19(2 Pt 1):220-224.